Marie M. Michelsen

Soborg, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials.

Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials.

Journal: European journal of heart failure

Published: January 16, 2026

Semaglutide reduces the risk of major adverse cardiovascular events consistently across baseline triglyceride levels in patients with type 2 diabetes: Post hoc analyses of the SUSTAIN 6 and PIONEER 6 trials.

Semaglutide reduces the risk of major adverse cardiovascular events consistently across baseline triglyceride levels in patients with type 2 diabetes: Post hoc analyses of the SUSTAIN 6 and PIONEER 6 trials.

Journal: Diabetes, obesity & metabolism

Published: January 05, 2023

Impaired coronary flow velocity reserve is associated with cardiovascular risk factors but not with angina symptoms.

Impaired coronary flow velocity reserve is associated with cardiovascular risk factors but not with angina symptoms.

Journal: Open heart

Published: October 15, 2020

Proteoglycan Remodeling Is Accelerated in Females with Angina Pectoris and Diffuse Myocardial Fibrosis: the iPOWER Study.

Proteoglycan Remodeling Is Accelerated in Females with Angina Pectoris and Diffuse Myocardial Fibrosis: the iPOWER Study.

Journal: Journal of cardiovascular translational research

Published: September 07, 2020

Vital exhaustion in women with chest pain and no obstructive coronary artery disease: the iPOWER study.

Vital exhaustion in women with chest pain and no obstructive coronary artery disease: the iPOWER study.

Journal: Evidence-based mental health

Published: August 27, 2020

Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study.

Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study.

Journal: European heart journal

Published: June 18, 2020

Inflammation, non-endothelial dependent coronary microvascular function and diastolic function-Are they linked?

Inflammation, non-endothelial dependent coronary microvascular function and diastolic function-Are they linked?

Journal: PloS one

Published: February 09, 2020

Myocardial CT perfusion compared with transthoracic Doppler echocardiography in evaluation of the coronary microvascular function: An iPOWER substudy.

Myocardial CT perfusion compared with transthoracic Doppler echocardiography in evaluation of the coronary microvascular function: An iPOWER substudy.

Journal: Clinical physiology and functional imaging

Published: January 11, 2020

Semaglutide improves health-related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6).

Semaglutide improves health-related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6).

Journal: Diabetes, obesity & metabolism

Published: December 23, 2019

Evaluation of computed tomography myocardial perfusion in women with angina and no obstructive coronary artery disease.

Evaluation of computed tomography myocardial perfusion in women with angina and no obstructive coronary artery disease.

Journal: The international journal of cardiovascular imaging

Published: August 15, 2019

Coronary microvascular dysfunction is associated with cardiac time intervals in women with angina and no obstructive coronary artery disease: An iPOWER substudy.

Coronary microvascular dysfunction is associated with cardiac time intervals in women with angina and no obstructive coronary artery disease: An iPOWER substudy.

Journal: Echocardiography (Mount Kisco, N.Y.)

Published: March 04, 2019

Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction.

Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction.

Journal: International journal of cardiology. Heart & vasculature

Published: January 25, 2019

Showing 1-12 of 35

Last Updated: 09/26/2026